Clinical trial
Evaluation of Dosing Chart Taking Into Account Age and Gender for Calculating the First Dose of Doxapram in Premature Infants
NCT00389909 is registered in ClinicalTrials.gov with Jean Michel Hascoet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Dosing Chart Taking Into Account Age and Gender for Calculating the First Dose of Doxapram in Premature Infants
- Lead sponsor
- Jean Michel Hascoet
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- November 30, 2010
- Enrollment
- 85 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
apnea, premature infants